Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: the Medication-Related Burden Quality of Life (MRB-QoL) tool
Open Access
Abstract
Objective Medication-related burden (MRB) is a negative experience with medicine, which may impact on psychological, social, physical and financial well-being of an individual. This study describes the development and initial validation of an instrument specifically designed to measure MRB on functioning and well-being—the Medication-Related Burden Quality of Life (MRB-QoL) tool. Methods An initial pool of 76-items for MRB-QoL was generated. The link to MRB-QoL survey was sent to a sample of consumers living with at least one chronic medical condition and taking ≥3 prescription medicines on a regular basis. Exploratory factor analysis (EFA) was used to determine the underlining factor structure. Internal consistency (Cronbach’s α) and construct validity were examined. The latter was examined through correlation with Medication Regimen Complexity Index (MRCI), Drug Burden Index (DBI) and Charlson’s Comorbidity Index (CCI). Results 367 consumers completed the survey (51.2% male). EFA resulted in a 31-item, five-factor solution explaining 72% of the total variance. The five subscales were labelled as ‘Routine and Regimen Complexity’ (11 items), ‘Psychological Burden’ (six items), ‘Functional and Role Limitation’ (seven items), ‘Therapeutic Relationship’ (three items) and ‘Social Burden’ (four items). All subscales showed good internal consistency (Cronbach’s α 0.87 to 0.95). Discriminant validity of MRB-QoL was demonstrated via its correlations with MRCI (Spearman’s r −0.16 to 0.08), DBI (r 0.12 to 0.28) and CCI (r −0.23 to −0.15). Correlation between DBI and ‘Functional and Role Limitation’ subscale (r 0.36) indicated some evidence of convergent validity. Patients with polypharmacy, multiple morbidity and DBI >0 had higher median scores of MRB-QoL providing evidence for known group validity. Conclusions The MRB-QoL V.1 has good construct validity and internal consistency. The MRB-QoL may be a useful humanistic measure for evaluating the impact of pharmaceutical care interventions on patients’ quality of life. Future research is warranted to further examine additional psychometric properties of MRB-QoL V.1 and its utility in patient care.Keywords
This publication has 55 references indexed in Scilit:
- Drug Burden Index, Physical Function, and Adverse Outcomes in Older Hospitalized PatientsThe Journal of Clinical Pharmacology, 2012
- Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditionsBMC Medicine, 2012
- Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in GermanyBMC Public Health, 2011
- Prevalence estimates of multimorbidity: a comparative study of two sourcesBMC Health Services Research, 2010
- Drug Burden Index Score and Functional Decline in Older PeopleThe American Journal of Medicine, 2009
- Drug Burden Index and physical function in older Australian menBritish Journal of Clinical Pharmacology, 2009
- Does pharmacist‐led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta‐analysisBritish Journal of Clinical Pharmacology, 2007
- Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of lifeResearch in Social and Administrative Pharmacy, 2006
- Pharmaceutical Care Services for Asthma Patients: A Controlled Intervention StudyThe Journal of Clinical Pharmacology, 2001
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951